Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
44 Cards in this Set
- Front
- Back
rapid acting insulin drugs (3)
|
lispro
aspart regular |
|
intermediate acting insulin drugs (1)
|
NPH
|
|
long acting insulin drugs (2)
|
glargine
detemir |
|
action of insulin drugs
- main (1) - liver (2) - muscle (3) - fat (4) |
1 - bind insulin R.
2. increase glycogen storage 3. increase glycogen and protein synthesis, K+ uptake 4. help TG storage |
|
insulin drugs are used clinically for? (5)
|
1. type 1 DM
2. type 2 DM 3. gestational DM 4. life threatening hyperkalemia 5. stress-induced hyperglycemia |
|
toxicities of insulin drugs (2)
|
1. hypoglycemia
2. hypersensitivity - rare |
|
first generation sulfonylurea drugs (2)
|
tolbutamide
chlorpropamide |
|
second generation sulfonylurea drugs (3)
|
glyburide
glimepride glipizide |
|
action of sulfonylurea drugs
|
close K+ channel on B cell membrane --> cell depolarizes and triggers insulin release via increases Ca2+ influx
|
|
clinical use of sulfonylurea drugs
|
stimulate endogenous insulin secretion in type 2 DM
|
|
side effects of first generation sulfonylurea drugs
|
disulfiram-like effects
|
|
side effects of second generation sulfonylurea drugs
|
hypoglycemia
|
|
examples of biguanide drug
|
Metformin
|
|
actions of Metformin (3)
|
decreases gluconeogenesis
increases glycolysis increases peripheral glucose uptake |
|
clinical notes about Metformin (2)
|
PO admin
can be used in pts w/o islet cell function |
|
adverse effect of Metformin
|
lactic acidosis
C/I in renal failure |
|
glitazone drugs (2)
|
pioglitazone
rosiglitazone |
|
mechanism of action of glitazones
|
increase insulin sensitivity in peripheral tissues --> binds to PPARy txn regulator
|
|
clinical use of glitazones
|
uses as monotherapy in type 2DM
|
|
adverse effects of glitazones (4)
|
1. weight gain
2. edema 3. hepatotoxicity 4. CV toxicity |
|
a-glucosidase inhibitors (2)
|
acarbose
miglitol |
|
action of a-glucosidase inhibitors
|
inhibit intestinal brush border a-glucosidases --> delayed sugar hydrolysis and absorprtion post-prandially
|
|
clinical use of a-glucosidase inhibitors
|
monotherapy for DM2
|
|
adverse effects of a-glucosidase inhibitors
|
GI disturbances
|
|
pramlintide
|
decreases glucagon
used for DM2 |
|
adverse effects of pramlintide (3)
|
hypoglycemia
nausea diarrhea |
|
GLP1 analogs
|
exenatide
-- type 2 DM |
|
action of GLP1 analogs (2)
|
1. increase insulin
2. decrease glucagon release |
|
adverse effects of GLP-1 analogs (3)
|
nausea
vomiting pancreatitis |
|
Tx. of hyperthyroidism ? (2)
|
1. propylthiouracil
2. methimazole |
|
mechanism of action of propythiouracile and methimazole
|
inhibitor organification of iodide and coupling of TH synthesis
- PTU decrease peripheral conversion of T4-->T3 |
|
propylthiouracil
methimazole --> adverse effects (4) |
11. skin rash
2. agranulocytosis - rare 3. aplastic anemia 4. teratogenic - methimazole |
|
drugs used for thyroxine replacement (2)
|
1. hypothyroidism
2. myxedema |
|
toxicity of levothyroxine (methimazole)
|
1. tachycardia
2. heat intolerance 3. tremors 4. arrhythmias |
|
octreotide
|
somatostatin analogue
|
|
clinical uses of octreotide (4)
|
1. acromegaly
2. carcinoid 3. gastrinoma 4. glucagonoma |
|
desmopressin
|
ADH analogue
|
|
clinical uses of desmopressin
|
central diabetes insipidus
|
|
demeclocycline
|
ADH antagonist
--> tetracycline family |
|
clinical use of demeclocycline
|
SIADH
|
|
toxicity of demeclocycline (3)
|
1. nephrogenic DI
2. photosensitivity 3. abnormalities of bones/teeth |
|
glucocorticoids - names (5)
|
hydrocortisone
prednisone triamcinolone dexamethosone beclomethasone |
|
clinical uses of glucocorticoids (4)
|
1. addison's disease
2. inflammation 3. immune suppression 4. asthma |
|
toxicities of glucocorticoids (2)
|
1. iatrogenic Cushing's syndrome
2. adrenal insufficiency if drug stopped abruptly after chronic use |